India, June 11 -- MIND Technology, Inc. (MIND), a defense and marine technology company, reported narrower loss for the first quarter of fiscal 2027, attributable to higher revenue from the sales of m... Read More
India, June 11 -- Kinepolis Group SA (KPSN.F,KIN.BR), a Belgian cinema operator, Thursday said that it has agreed to acquire Showcase Cinemas in the US from Harbor Lights Entertainment, formerly Natio... Read More
India, June 11 -- European stocks may open lower on Thursday amid U.S.-Iran tensions and interest-rate hike concerns. Technology stocks could be in focus after Oracle reported quarterly capital expend... Read More
India, June 11 -- The monetary policy announcement from the European Central Bank is the top economic news due on Thursday. At 2.00 am ET, Statistics Sweden publishes inflation data for May. Economis... Read More
India, June 11 -- CytoDyn Inc. (CYDY), a clinical-stage oncology company, on Thursday announced dosing of the first patient in the Phase 2a SALIENT-AD trial for Leronlimab in treating Alzheimer's dise... Read More
India, June 11 -- NEOJAPAN Inc. (3921.T) announced a profit for its first quarter that Increased, from the same period last year The company's bottom line totaled JPY487 million, or JPY34.78 per shar... Read More
India, June 11 -- Indian shares opened lower on Thursday, tracking weak cues from global markets amid concerns over rising U.S.-Iran tensions and potential Federal Reserve rate hikes later this year. ... Read More
India, June 11 -- Cosmos Health Inc. (COSM), an integrated healthcare company, on Thursday announced receiving a 180-day extension on June 10, 2026, from The Nasdaq Stock Market LLC to regain complian... Read More
India, June 11 -- Genmab A/S (GMAB) on Thursday presented new subgroup data from the Phase 3 EPCORE FL-1 trial showing that epcoritamab in combination with rituximab and lenalidomide (R2) delivered co... Read More
India, June 10 -- Rafael Holdings, Inc. (RFL), a clinical and early-stage biopharmaceutical company, announced that its last patient has completed their final 96-week study visit in the pivotal Phase ... Read More